Long-acting GHRH analog with drug affinity complex. Supplied lyophilized under argon.
$78/ 5mg
Figures are illustrative of published preclinical research and are provided for orientation only. They are not claims about this product.
CJC-1295 with DAC is a synthetic analog of growth hormone-releasing hormone, modified with a drug affinity complex that substantially extends its circulating half-life relative to the unmodified peptide. It is supplied lyophilised under inert atmosphere.
Signalling pathways examined in preclinical models. Descriptive of published research directions, not claims of effect.
Characterised in receptor-binding studies against the growth hormone-releasing hormone receptor on pituitary-derived cell lines.
The drug affinity complex is designed to form a covalent bond with serum albumin, which is the mechanism by which circulating duration is extended in preclinical models.
Used as a reference standard in preclinical work examining growth hormone secretory dynamics.
Employed as a characterised standard when developing LC-MS methods for long-acting peptide conjugates.
Illustrative of published preclinical findings. Not a representation of this product’s performance, and not a claim of any effect in humans.
HPLC purity
RP-HPLC, 214 nm
Identity
LC-MS
Endotoxin (LAL)
Kinetic chromogenic
Heavy metals
ICP-MS
Net peptide content
Nitrogen analysis
Residual solvents
Headspace GC
Lot LP-2601-B
Still unsure? Ask the lab — median response under four hours.
DAC stands for drug affinity complex — a chemical modification that allows the peptide to bind serum albumin, substantially extending its circulating half-life in preclinical models compared with the unmodified analog.
Store the sealed vial at −20°C for long-term stability and 2–8°C for short-term handling. Protect from light and avoid repeated freeze-thaw cycles. Compound-specific stability data is printed on the certificate of analysis supplied with the lot.
This material is supplied as a reference standard for in-vitro laboratory research only. It has not been evaluated by the FDA, is not a drug, and is not intended for human or veterinary use. Handling should follow your institution's chemical hygiene plan, including appropriate PPE and documented disposal.
Independent published research relating to this compound. Listed for reference; Lumen Peptides, Inc. is not affiliated with these authors and makes no claims based on their findings.
Prolonged stimulation of growth hormone by CJC-1295
Teichman SL et al. · 2006 · J Clin Endocrinol Metab
Human growth hormone-releasing factor conjugate
Jetté L et al. · 2005 · Endocrinology
For laboratory research use only. All compounds listed on this site are sold strictly as reference materials for in-vitro laboratory research conducted by qualified professionals. They are not drugs, foods, cosmetics, or medical devices. They are not intended for human or veterinary consumption, therapeutic use, diagnostic application, or any in-vivo use whatsoever. These statements have not been evaluated by the Food and Drug Administration. By purchasing, you affirm that you are a qualified researcher and that you will comply with all applicable institutional, local, state and federal regulations governing the handling of research chemicals.
Compounds supplied through this catalog are reference materials for in-vitro laboratory research. Confirm your status to continue.
HELLO STIO 👋
Hey handsome — I built you a website.
— Rob
By entering you agree to our Terms & Research-Use Policy. These products have not been evaluated by the FDA and are not for human consumption. © 2026 Lumen Peptides, Inc.
Analytics cookies
We’d like to measure how the catalog is used, which sets cookies and shares activity with Meta. Nothing loads until you choose, and declining does not affect your order. Privacy policy